Qingxue Li1, Jeffrey I Cohen1. 1. Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Abstract
PURPOSE: While most adults are infected Epstein-Barr virus (EBV), 3-5% remain uninfected. The human leukocyte antigen (HLA) complex, which controls many pathogens, may influence infection and disease associated with EBV. RECENT FINDINGS: Numerous EBV proteins and miRNAs down-regulate HLA class I and II expression on the cell surface. HLA class II functions as a receptor for EBV entry into B cells. Specific HLA class II alleles correlate with the susceptibility of B cells to EBV infection in vitro and with EBV seropositivity or seronegativity of humans. HLA class I polymorphisms correlate with development and severity of EBV infectious mononucleosis and with the risk of several virus-associated malignancies including nasopharyngeal carcinoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disease. SIGNIFICANCE: These findings indicate that while EBV has evolved to use MHC class II as a receptor for virus entry, polymorphisms in MHC class II and class I influence virus infection and disease.
PURPOSE: While most adults are infected Epstein-Barr virus (EBV), 3-5% remain uninfected. The human leukocyte antigen (HLA) complex, which controls many pathogens, may influence infection and disease associated with EBV. RECENT FINDINGS: Numerous EBV proteins and miRNAs down-regulate HLA class I and II expression on the cell surface. HLA class II functions as a receptor for EBV entry into B cells. Specific HLA class II alleles correlate with the susceptibility of B cells to EBV infection in vitro and with EBV seropositivity or seronegativity of humans. HLA class I polymorphisms correlate with development and severity of EBV infectious mononucleosis and with the risk of several virus-associated malignancies including nasopharyngeal carcinoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disease. SIGNIFICANCE: These findings indicate that while EBV has evolved to use MHC class II as a receptor for virus entry, polymorphisms in MHC class II and class I influence virus infection and disease.
Authors: Manon Delahaye-Sourdeix; Kevin Y Urayama; Valérie Gaborieau; Rianne Veenstra; Matthieu Foll; Amelie Chabrier; Yolanda Benavente; Alexandra Nieters; Nikolaus Becker; Lenka Foretova; Marc Maynadié; Anthony Staines; Karin Ekstrom Smedby; Ingrid Glimelius; Tracy Lightfoot; Pierluigi Cocco; Pilar Galan; Lars J Vatten; Eric J Duell; Lambertus Kiemeney; Eve Roman; Silvia de Sanjosé; Mark Lathrop; Mads Melbye; Paul Brennan; Arjan Diepstra; Anke van den Berg; Henrik Hjalgrim; Ruth F Jarrett; James D McKay Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-24 Impact factor: 4.254
Authors: Marion Subklewe; René Marquis; Sylvain Choquet; Veronique Leblond; Jeanne-Luce Garnier; Roland Hetzer; Lode J Swinnen; Stephan Oertel; Matthias Papp-Vary; Eva Gonzalez-Barca; Bouke G Hepkema; Constanze Schoenemann; Juergen May; Antonio Pezzutto; Hanno Riess Journal: Transplantation Date: 2006-10-27 Impact factor: 4.939
Authors: James Robinson; Jason A Halliwell; James D Hayhurst; Paul Flicek; Peter Parham; Steven G E Marsh Journal: Nucleic Acids Res Date: 2014-11-20 Impact factor: 16.971
Authors: Luke B Fletcher; Rianne N Veenstra; Eric Y Loo; Amie E Hwang; Imran N Siddiqi; Lydia Visser; Bouke G Hepkema; Ilja M Nolte; Anke van den Berg; Wendy Cozen; Arjan Diepstra Journal: PLoS One Date: 2017-03-23 Impact factor: 3.240
Authors: Tommi Välikangas; Niina Lietzén; Maria K Jaakkola; Lars Krogvold; Morten C Eike; Henna Kallionpää; Soile Tuomela; Clayton Mathews; Ivan C Gerling; Sami Oikarinen; Heikki Hyöty; Knut Dahl-Jorgensen; Laura L Elo; Riitta Lahesmaa Journal: Front Endocrinol (Lausanne) Date: 2022-04-13 Impact factor: 6.055
Authors: Kay Poulton; Paul Wright; Pamela Hughes; Sinisa Savic; Matthew Welberry Smith; Malcolm Guiver; Muir Morton; David van Dellen; Eleni Tholouli; Robert Wynn; Brendan Clark Journal: Int J Immunogenet Date: 2020-07-05 Impact factor: 2.385